M
Michael G. Shlipak
Researcher at University of California, San Francisco
Publications - 667
Citations - 57579
Michael G. Shlipak is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 111, co-authored 612 publications receiving 50319 citations. Previous affiliations of Michael G. Shlipak include National Kidney Foundation & Wake Forest University.
Papers
More filters
Journal ArticleDOI
Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
Adeera Levin,Paul E. Stevens,Rudy Bilous,Josef Coresh,Alm deFrancisco,Pe Dejong,K.E. Griffith,Brenda R. Hemmelgarn,Kunitoshi Iseki,EJ Lamb,Andrew S. Levey,Miguel C. Riella,Michael G. Shlipak,Hongya Wang,Colin T. White,Christopher G. Winearls +15 more
Journal ArticleDOI
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita,Marije van der Velde,Brad C. Astor,Mark Woodward,Andrew S. Levey,Paul E. de Jong,Josef Coresh,Ron T. Gansevoort,Meguid El-Nahas,Kai-Uwe Eckardt,Bertram L. Kasiske,Marcello Tonelli,Brenda R. Hemmelgarn,Yaping Wang,Robert C. Atkins,Kevan R. Polkinghorne,Steven J. Chadban,Anoop Shankar,Ronald Klein,Barbara E.K. Klein,Haiyan Wang,Fang Wang,Luxia Zhang,Lisheng Liu,Michael G. Shlipak,Mark J. Sarnak,Ronit Katz,Linda Fried,Tazeen H. Jafar,M. Mazharul Islam,Juanita Hatcher,Neil R Poulter,Nish Chaturvedi,Dietrich Rothenbacher,Hermann Brenner,Elke Raum,Wolfgang Koenig,Caroline S. Fox,Shih-Jen Hwang,James B. Meigs,Massimo Cirillo,Stein Hallan,Stian Lydersen,Jostein Holmen,Paul Roderick,Dorothea Nitsch,Astrid E. Fletcher,Christopher J. Bulpitt,Takayoshi Ohkubo,Hirohito Metoki,Masaaki Nakayama,Masahiro Kikuya,Yutaka Imai,Simerjot K. Jassal,Elizabeth Barrett-Connor,Jaclyn Bergstrom,David G. Warnock,Paul Muntner,Suzanne E. Judd,William M. McClellan,Mary Cushman,George Howard,Leslie A. McClure,Sun Ha Jee,Heejin Kimm,Ji Eun Yun,Chi Pang Wen,Sung Feng Wen,Chwen Keng Tsao,Min Kuang Tsai,Johan Ärnlöv,Priscilla Auguste,Kasper Veldhuis,Laura Camarata,Beverly Thomas,Tom Manley +75 more
TL;DR: In this article, a meta-analysis of general population cohorts was conducted to assess the independent and combined associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality.
Journal ArticleDOI
Cystatin C and the risk of death and cardiovascular events among elderly persons.
Michael G. Shlipak,Mark J. Sarnak,Ronit Katz,Linda F. Fried,Stephen L. Seliger,Anne B. Newman,David S. Siscovick,Catherine Stehman-Breen +7 more
TL;DR: Cystatin C, a serum measure of renal function, is a stronger predictor of the risk of death and cardiovascular events in elderly persons than is creatinine.
Journal ArticleDOI
Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis
Steven G. Coca,Bushra Yusuf,Bushra Yusuf,Michael G. Shlipak,Michael G. Shlipak,Amit X. Garg,Chirag R. Parikh,Chirag R. Parikh +7 more
TL;DR: The development of AKI, defined as acute changes in serum creatinine level, characterizes hospitalized patients at increased risk of long-term adverse outcomes and was unattainable because of lack of follow-up of appropriate controls without AKI.
Journal ArticleDOI
Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis
Grace L. Smith,Judith H. Lichtman,Michael B. Bracken,Michael G. Shlipak,Michael G. Shlipak,Christopher O. Phillips,Paul DiCapua,Harlan M. Krumholz +7 more
TL;DR: In this article, the authors estimated the prevalence of renal impairment in heart failure patients and the magnitude of associated mortality risk using a systematic review of published studies and found that renal impairment is associated with excess mortality, although precise risk estimates are unclear.